Ameliorant for chemical treatment of cancer
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 9, 2008
Grant Date -
Sep 29, 2005
app pub date -
Mar 26, 2002
filing date -
Mar 26, 2002
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
An ameliorating agent for cancer chemotherapy is disclosed, which comprises a chromanol glycoside represented by the following general formula (1) ##STR00001## (wherein R.sup.1, R.sup.2, R.sup.3, and R.sup.4, which are identical or different from each other, stand for a hydrogen atom or a lower alkyl group, R.sup.5 stands for a hydrogen atom, a lower alkyl group, or a lower acyl group, X stands for a monosaccharide residue or an oligosaccharide residue optionally having the hydrogen atom of the hydroxyl group in the saccharide residue substituted with a lower alkyl group or a lower acyl group, n is an integer in the range of 0-6, and m is an integer in the range of 1-6).According to this invention, a novel ameliorating agent for cancer chemotherapy is provided which acts safely and effectively in a small dosage to enhance the carcinostatic action of an anti-cancer agent in cancer chemotherapy and repressing side effects by cancer chemotherapy as well.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully